ZNF610
gene geneOn this page
Also known as FLJ36040
Summary
ZNF610 (zinc finger protein 610, HGNC:26687) is a protein-coding gene on chromosome 19q13.41, encoding Zinc finger protein 610 (Q8N9Z0). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 162963 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 77 total
- MANE Select transcript:
NM_001161425
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26687 |
| Approved symbol | ZNF610 |
| Name | zinc finger protein 610 |
| Location | 19q13.41 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ36040 |
| Ensembl gene | ENSG00000167554 |
| Ensembl biotype | protein_coding |
| Entrez | 162963 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 8 protein_coding, 2 retained_intron
ENST00000321287, ENST00000327920, ENST00000403906, ENST00000593698, ENST00000594919, ENST00000599508, ENST00000601151, ENST00000613461, ENST00000616431, ENST00000927695
RefSeq mRNA: 4 — MANE Select: NM_001161425
NM_001161425, NM_001161426, NM_001161427, NM_173530
CCDS: CCDS12851, CCDS54309
Canonical transcript exons
ENST00000403906 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001509748 | 52347707 | 52347944 |
| ENSE00002470175 | 52349154 | 52349235 |
| ENSE00002486704 | 52353682 | 52353808 |
| ENSE00002504046 | 52354251 | 52354379 |
| ENSE00002976700 | 52365698 | 52367778 |
| ENSE00003081720 | 52336243 | 52336506 |
Expression profiles
Bgee: expression breadth ubiquitous, 190 present calls, max score 91.68.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.9761 / max 47.3264, expressed in 1099 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177299 | 2.2504 | 968 |
| 177298 | 0.6283 | 376 |
| 177301 | 0.0827 | 24 |
| 177300 | 0.0148 | 4 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 91.68 | gold quality |
| secondary oocyte | CL:0000655 | 88.52 | gold quality |
| ventricular zone | UBERON:0003053 | 86.53 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.03 | gold quality |
| ganglionic eminence | UBERON:0004023 | 85.68 | gold quality |
| cortical plate | UBERON:0005343 | 84.69 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.20 | gold quality |
| right testis | UBERON:0004534 | 78.53 | gold quality |
| pancreatic ductal cell | CL:0002079 | 77.58 | silver quality |
| testis | UBERON:0000473 | 77.55 | gold quality |
| left testis | UBERON:0004533 | 77.42 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 74.95 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.37 | gold quality |
| left ovary | UBERON:0002119 | 74.11 | gold quality |
| right uterine tube | UBERON:0001302 | 73.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.83 | gold quality |
| caudate nucleus | UBERON:0001873 | 73.73 | gold quality |
| spinal cord | UBERON:0002240 | 73.52 | gold quality |
| sperm | CL:0000019 | 73.30 | gold quality |
| gall bladder | UBERON:0002110 | 73.19 | gold quality |
| tibialis anterior | UBERON:0001385 | 73.16 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 73.04 | gold quality |
| ovary | UBERON:0000992 | 72.79 | gold quality |
| putamen | UBERON:0001874 | 72.69 | gold quality |
| nucleus accumbens | UBERON:0001882 | 72.62 | gold quality |
| hypothalamus | UBERON:0001898 | 72.36 | gold quality |
| right ovary | UBERON:0002118 | 72.17 | gold quality |
| adrenal tissue | UBERON:0018303 | 72.14 | gold quality |
| islet of Langerhans | UBERON:0000006 | 72.10 | gold quality |
| right adrenal gland | UBERON:0001233 | 71.97 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | no | 92.39 |
| E-ANND-3 | no | 4.74 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1713.1 | ZNF610 | More than 3 adjacent zinc fingers |
| MA1713.2 | ZNF610 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28273063
miRNA regulators (miRDB)
26 targeting ZNF610, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-4530 | 99.69 | 66.47 | 1509 |
| HSA-MIR-10393-5P | 99.65 | 68.01 | 1368 |
| HSA-MIR-4276 | 99.56 | 67.66 | 2514 |
| HSA-MIR-4762-3P | 99.43 | 69.72 | 2363 |
| HSA-MIR-3911 | 99.38 | 66.95 | 1087 |
| HSA-MIR-3145-3P | 98.85 | 69.07 | 2031 |
| HSA-MIR-3188 | 98.58 | 65.60 | 878 |
| HSA-MIR-2117 | 98.48 | 67.97 | 1307 |
| HSA-MIR-6792-3P | 98.41 | 66.86 | 1359 |
| HSA-MIR-10397-3P | 97.78 | 65.70 | 601 |
| HSA-MIR-4765 | 93.11 | 66.17 | 737 |
Literature-anchored findings (GeneRIF, showing 1)
- Silencing of ZNF610 suppresses cell proliferation and migration in lung adenocarcinoma. (PMID:38898665)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfx | ENSDARG00000074453 |
| danio_rerio | ENSDARG00000098424 | |
| mus_musculus | Zfy2 | ENSMUSG00000000103 |
| mus_musculus | Zfy1 | ENSMUSG00000053211 |
| rattus_norvegicus | Zfy1 | ENSRNOG00000053042 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 610 — Q8N9Z0 (reviewed: Q8N9Z0)
All UniProt accessions (2): Q8N9Z0, M0QYM6
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N9Z0-1 | 1 | yes |
| Q8N9Z0-2 | 2 |
RefSeq proteins (4): NP_001154897, NP_001154898, NP_001154899, NP_775801 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465
UniProt features (19 total): zinc finger region 9, sequence variant 4, cross-link 3, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N9Z0-F1 | 65.82 | 0.26 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 119, 122, 194
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins |
MSigDB gene sets: 27 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP, GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZNF528_TARGET_GENES, MIR4753_3P, MIR551B_5P, MIR6873_3P, MIR3064_3P, WRNIP1_TARGET_GENES, HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE, GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
| Regulation of endogenous retroelements | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
330 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF610 | OPLAH | O14841 | 417 |
| ZNF610 | FAM135B | Q49AJ0 | 411 |
| ZNF610 | TSPYL5 | Q86VY4 | 399 |
| ZNF610 | ZC2HC1A | Q96GY0 | 377 |
| ZNF610 | ARHGEF4 | Q9NR80 | 370 |
| ZNF610 | LRRC26 | Q2I0M4 | 323 |
| ZNF610 | TBX15 | Q96SF7 | 322 |
| ZNF610 | GIMAP6 | Q6P9H5 | 307 |
| ZNF610 | DMRTA2 | Q96SC8 | 304 |
| ZNF610 | VWC2 | Q2TAL6 | 301 |
| ZNF610 | GRIN2D | O15399 | 280 |
| ZNF610 | RSPO2 | Q6UXX9 | 276 |
| ZNF610 | MIA2 | Q96PC5 | 272 |
| ZNF610 | PCDH10 | Q9P2E7 | 270 |
| ZNF610 | EMX1 | Q04741 | 254 |
| ZNF610 | SORCS3 | Q9UPU3 | 254 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF610 | CDC37 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF610 | TRIM37 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (10): TRIM37 (Affinity Capture-MS), TUBA3C (Affinity Capture-MS), HERC1 (Affinity Capture-MS), ZNF610 (Affinity Capture-MS), PLEKHA1 (Affinity Capture-MS), TRIM37 (Affinity Capture-MS), HERC1 (Affinity Capture-MS), TUBA3C (Affinity Capture-MS), ZNF610 (Affinity Capture-MS), ZNF610 (Affinity Capture-MS)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
77 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 67 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1162 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:52349066:GAT:G | donor_gain | 1.0000 |
| 19:52349150:TTAG:T | acceptor_loss | 1.0000 |
| 19:52349151:TAGG:T | acceptor_loss | 1.0000 |
| 19:52349152:A:AT | acceptor_loss | 1.0000 |
| 19:52349153:GGATT:G | acceptor_gain | 1.0000 |
| 19:52353680:A:G | acceptor_loss | 1.0000 |
| 19:52353680:AG:A | acceptor_gain | 1.0000 |
| 19:52353681:GG:G | acceptor_gain | 1.0000 |
| 19:52353681:GGGAC:G | acceptor_gain | 1.0000 |
| 19:52365692:TTCTA:T | acceptor_loss | 1.0000 |
| 19:52365693:TCTA:T | acceptor_loss | 1.0000 |
| 19:52365694:CTA:C | acceptor_loss | 1.0000 |
| 19:52365695:TAG:T | acceptor_loss | 1.0000 |
| 19:52365696:AGGG:A | acceptor_loss | 1.0000 |
| 19:52365697:G:A | acceptor_loss | 1.0000 |
| 19:52347208:G:GT | donor_gain | 0.9900 |
| 19:52347244:GCC:G | donor_gain | 0.9900 |
| 19:52349152:A:AG | acceptor_gain | 0.9900 |
| 19:52349153:G:GG | acceptor_gain | 0.9900 |
| 19:52349231:CTCAG:C | donor_loss | 0.9900 |
| 19:52349232:TCAG:T | donor_loss | 0.9900 |
| 19:52349233:CAGGT:C | donor_loss | 0.9900 |
| 19:52349234:AGGT:A | donor_loss | 0.9900 |
| 19:52349235:GGT:G | donor_loss | 0.9900 |
| 19:52349236:G:A | donor_loss | 0.9900 |
| 19:52349237:T:A | donor_loss | 0.9900 |
| 19:52353675:A:AG | acceptor_gain | 0.9900 |
| 19:52353676:TTTTA:T | acceptor_gain | 0.9900 |
| 19:52353677:TTTAG:T | acceptor_gain | 0.9900 |
| 19:52353680:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000049927 (19:52351929 C>G), RS1000140129 (19:52362925 A>C,G), RS1000148420 (19:52356490 T>C), RS1000232582 (19:52342451 A>G), RS1000280489 (19:52341240 T>C), RS1000388452 (19:52346911 G>C), RS1000405776 (19:52352380 A>G), RS1000617554 (19:52342581 G>A), RS1000730326 (19:52342302 A>G), RS1000931457 (19:52362993 G>A), RS1000993518 (19:52362796 T>G), RS1001118931 (19:52332116 G>C), RS1001164667 (19:52341502 G>A), RS1001281003 (19:52357286 G>T), RS1001301146 (19:52339386 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, increases expression | 4 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol A | decreases expression | 1 |
| trichostatin A | increases expression | 1 |
| arsenite | increases reaction, affects binding | 1 |
| sodium arsenite | decreases expression | 1 |
| butylbenzyl phthalate | increases expression | 1 |
| nickel sulfate | decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation, increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Estradiol | affects expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD33 | HEK293 eGFP-ZNF610 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.